AIM: The aim of the study was to determine whether the clinical benefits of galantamine for patients with Alzheimer's disease lead to benefits for caregivers. METHODS: Data were pooled from two concurrent, multi-centre, randomized, double-blind, placebo-controlled, 6-month trials. Time caregivers spent assisting with activities of daily living (ADL) and time patients could be left unsupervised each day were assessed using the Allocation of Caregiver Time Survey. In total, 825 patients with m...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
The effects of galantamine treatment on caregiver time in Alzheimer's disease.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record